Nurix Therapeutics Inc. (NRIX) at a glance

Nurix Therapeutics Inc. (NRIX) is a small-cap Healthcare company. It trades at $26.23, with a 0% profit margin and revenue decline of 66.1%. It does not pay a dividend. Vestovix scores it 34/100 overall. Its strongest dimension is Momentum (80/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price

$26.24

Market cap

$1.75B

P/E ratio

n/a

Dividend yield

None

Beta

1.87

52-week range

$8.20 to $28.23